THIS SOUNDS LIKE GOOD NEWS: “A next-generation leukemia pill designed to help patients not cured by the successful drug Gleevec works even better than doctors had hoped, researchers said Sunday. The new drug, made by Bristol-Myers Squibb put 86 percent of patients who tried it into remission — meaning signs of their cancer disappeared, the researchers said.”